IL13 and airway hyperresponsiveness: It has been reported that MT inhibited ovalbumin (OVA)-induced airway hyperresponsiveness (AHR) in mice by decreasing the production of IL-4 and IL-13, and increasing the expression of interferon (IFN)-γ.